Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.

Mary Catchpole, 19, has the same life-threatening genetic condition, activated PI3-Kinase delta syndrome (APDS) ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

IIT-BHU engineers develop innovative, low-cost nanoparticles to prevent blood clots, revolutionizing blood storage ...

Genomic research holds incredible promise for improving human health, but one major challenge has slowed its progress: ...

An international research team has achieved a significant breakthrough in research into the reproduction of dogrose. The ...

Hours of talks aimed at de-escalating fighting between Israel and Iran failed to produce a diplomatic breakthrough as the war ...

In an unprecedented scientific feat, researchers have bridged the gap between humans and humpback whales, achieving a ...

Recently, Knudsen assumed the CEO post at the Parker Institute for Cancer Immunotherapy — created by Sean Parker, Facebook's first president and the tech entrepreneur behind breakthrough ideas ...

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...